Pre-order Enquiry
Request Free Sample
Global Opioid-Induced Constipation Market Growth 2021-2026
SKU ID : LPI-18710640 | Publishing Date : 08-Jul-2021 | No. of pages : 103
Detailed TOC of Global Opioid-Induced Constipation Market Growth 2021-2026
1 Scope of the Report1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Opioid-Induced Constipation Consumption 2016-2026
2.1.2 Opioid-Induced Constipation Consumption CAGR by Region
2.2 Opioid-Induced Constipation Segment by Type
2.2.1 Methylnaltrexone Bromide
2.2.2 Lubiprostone
2.2.3 Naloxegol
2.2.4 Others
2.3 Opioid-Induced Constipation Sales by Type
2.3.1 Global Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
2.3.2 Global Opioid-Induced Constipation Revenue and Market Share by Type (2016-2021)
2.3.3 Global Opioid-Induced Constipation Sale Price by Type (2016-2021)
2.4 Opioid-Induced Constipation Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.4.3 Other
2.5 Opioid-Induced Constipation Sales by Application
2.5.1 Global Opioid-Induced Constipation Sale Market Share by Application (2016-2021)
2.5.2 Global Opioid-Induced Constipation Revenue and Market Share by Application (2016-2021)
2.5.3 Global Opioid-Induced Constipation Sale Price by Application (2016-2021)
3 Global Opioid-Induced Constipation by Company
3.1 Global Opioid-Induced Constipation Sales Market Share by Company
3.1.1 Global Opioid-Induced Constipation Sales by Company (2019-2021)
3.1.2 Global Opioid-Induced Constipation Sales Market Share by Company (2019-2021)
3.2 Global Opioid-Induced Constipation Revenue Market Share by Company
3.2.1 Global Opioid-Induced Constipation Revenue by Company (2019-2021)
3.2.2 Global Opioid-Induced Constipation Revenue Market Share by Company (2019-2021)
3.3 Global Opioid-Induced Constipation Sale Price by Company
3.4 Global Manufacturers Opioid-Induced Constipation Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Opioid-Induced Constipation Product Location Distribution
3.4.2 Players Opioid-Induced Constipation Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Opioid-Induced Constipation by Region
4.1 Global Opioid-Induced Constipation by Region
4.1.1 Global Opioid-Induced Constipation Sales by Region
4.1.2 Global Opioid-Induced Constipation Revenue by Region
4.2 Americas Opioid-Induced Constipation Sales Growth
4.3 APAC Opioid-Induced Constipation Sales Growth
4.4 Europe Opioid-Induced Constipation Sales Growth
4.5 Middle East & Africa Opioid-Induced Constipation Sales Growth
5 Americas
5.1 Americas Opioid-Induced Constipation Sales by Country
5.1.1 Americas Opioid-Induced Constipation Sales by Country (2016-2021)
5.1.2 Americas Opioid-Induced Constipation Revenue by Country (2016-2021)
5.2 Americas Opioid-Induced Constipation Sales by Type
5.3 Americas Opioid-Induced Constipation Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Opioid-Induced Constipation Sales by Region
6.1.1 APAC Opioid-Induced Constipation Sales by Region (2016-2021)
6.1.2 APAC Opioid-Induced Constipation Revenue by Region (2016-2021)
6.2 APAC Opioid-Induced Constipation Sales by Type
6.3 APAC Opioid-Induced Constipation Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Opioid-Induced Constipation by Country
7.1.1 Europe Opioid-Induced Constipation Sales by Country (2016-2021)
7.1.2 Europe Opioid-Induced Constipation Revenue by Country (2016-2021)
7.2 Europe Opioid-Induced Constipation Sales by Type
7.3 Europe Opioid-Induced Constipation Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Opioid-Induced Constipation by Country
8.1.1 Middle East & Africa Opioid-Induced Constipation Sales by Country (2016-2021)
8.1.2 Middle East & Africa Opioid-Induced Constipation Revenue by Country (2016-2021)
8.2 Middle East & Africa Opioid-Induced Constipation Sales by Type
8.3 Middle East & Africa Opioid-Induced Constipation Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Opioid-Induced Constipation Distributors
10.3 Opioid-Induced Constipation Customer
11 Global Opioid-Induced Constipation Market Forecast
11.1 Global Opioid-Induced Constipation Forecast by Region
11.1.1 Global Opioid-Induced Constipation Forecast by Regions (2021-2026)
11.2.2 Global Opioid-Induced Constipation Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global Opioid-Induced Constipation Forecast by Type
11.7 Global Opioid-Induced Constipation Forecast by Application
12 Key Players Analysis
12.1 Takeda Pharmaceuticals
12.1.1 Takeda Pharmaceuticals Company Information
12.1.2 Takeda Pharmaceuticals Opioid-Induced Constipation Product Offered
12.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 Takeda Pharmaceuticals Main Business Overview
12.1.5 Takeda Pharmaceuticals Latest Developments
12.2 Bayer
12.2.1 Bayer Company Information
12.2.2 Bayer Opioid-Induced Constipation Product Offered
12.2.3 Bayer Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 Bayer Main Business Overview
12.2.5 Bayer Latest Developments
12.3 Sanofi
12.3.1 Sanofi Company Information
12.3.2 Sanofi Opioid-Induced Constipation Product Offered
12.3.3 Sanofi Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 Sanofi Main Business Overview
12.3.5 Sanofi Latest Developments
12.4 Mallinckrodt
12.4.1 Mallinckrodt Company Information
12.4.2 Mallinckrodt Opioid-Induced Constipation Product Offered
12.4.3 Mallinckrodt Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Mallinckrodt Main Business Overview
12.4.5 Mallinckrodt Latest Developments
12.5 Salix (Bausch Health)
12.5.1 Salix (Bausch Health) Company Information
12.5.2 Salix (Bausch Health) Opioid-Induced Constipation Product Offered
12.5.3 Salix (Bausch Health) Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Salix (Bausch Health) Main Business Overview
12.5.5 Salix (Bausch Health) Latest Developments
12.6 AstraZeneca
12.6.1 AstraZeneca Company Information
12.6.2 AstraZeneca Opioid-Induced Constipation Product Offered
12.6.3 AstraZeneca Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 AstraZeneca Main Business Overview
12.6.5 AstraZeneca Latest Developments
12.7 Progenics Pharmaceuticals
12.7.1 Progenics Pharmaceuticals Company Information
12.7.2 Progenics Pharmaceuticals Opioid-Induced Constipation Product Offered
12.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Progenics Pharmaceuticals Main Business Overview
12.7.5 Progenics Pharmaceuticals Latest Developments
12.8 Purdue Pharm
12.8.1 Purdue Pharm Company Information
12.8.2 Purdue Pharm Opioid-Induced Constipation Product Offered
12.8.3 Purdue Pharm Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Purdue Pharm Main Business Overview
12.8.5 Purdue Pharm Latest Developments
12.9 Nektar Therapeutics
12.9.1 Nektar Therapeutics Company Information
12.9.2 Nektar Therapeutics Opioid-Induced Constipation Product Offered
12.9.3 Nektar Therapeutics Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Nektar Therapeutics Main Business Overview
12.9.5 Nektar Therapeutics Latest Developments
12.10 Daiichi Sankyo
12.10.1 Daiichi Sankyo Company Information
12.10.2 Daiichi Sankyo Opioid-Induced Constipation Product Offered
12.10.3 Daiichi Sankyo Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 Daiichi Sankyo Main Business Overview
12.10.5 Daiichi Sankyo Latest Developments
12.11 Prestige
12.11.1 Prestige Company Information
12.11.2 Prestige Opioid-Induced Constipation Product Offered
12.11.3 Prestige Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Prestige Main Business Overview
12.11.5 Prestige Latest Developments
12.12 GSK
12.12.1 GSK Company Information
12.12.2 GSK Opioid-Induced Constipation Product Offered
12.12.3 GSK Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 GSK Main Business Overview
12.12.5 GSK Latest Developments
12.13 Shionogi
12.13.1 Shionogi Company Information
12.13.2 Shionogi Opioid-Induced Constipation Product Offered
12.13.3 Shionogi Opioid-Induced Constipation Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 Shionogi Main Business Overview
12.13.5 Shionogi Latest Developments
13 Research Findings and Conclusion
List of Figures, Tables and Charts Available in Global Opioid-Induced Constipation Market Growth 2021-2026
List of TablesTable 1. Opioid-Induced Constipation Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Methylnaltrexone Bromide
Table 3. Major Players of Lubiprostone
Table 4. Major Players of Naloxegol
Table 5. Major Players of Others
Table 6. Global Opioid-Induced Constipation Sales by Type (2016-2021) & (K Units)
Table 7. Global Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
Table 8. Global Opioid-Induced Constipation Revenue by Type (2016-2021) & ($ million)
Table 9. Global Opioid-Induced Constipation Revenue Market Share by Type (2016-2021)
Table 10. Global Opioid-Induced Constipation Sale Price by Type (2016-2021)
Table 11. Global Opioid-Induced Constipation Sales by Application (2016-2021) & (K Units)
Table 12. Global Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
Table 13. Global Opioid-Induced Constipation Value by Application (2016-2021)
Table 14. Global Opioid-Induced Constipation Revenue Market Share by Application (2016-2021)
Table 15. Global Opioid-Induced Constipation Sale Price by Application (2016-2021)
Table 16. Global Opioid-Induced Constipation Sales by Company (2019-2021) & (K Units)
Table 17. Global Opioid-Induced Constipation Sales Market Share by Company (2019-2021)
Table 18. Global Opioid-Induced Constipation Revenue by Company (2019-2021) ($ Millions)
Table 19. Global Opioid-Induced Constipation Revenue Market Share by Company (2019-2021)
Table 20. Global Opioid-Induced Constipation Sale Price by Company (2019-2021)
Table 21. Key Manufacturers Opioid-Induced Constipation Producing Area Distribution and Sales Area
Table 22. Players Opioid-Induced Constipation Products Offered
Table 23. Opioid-Induced Constipation Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Opioid-Induced Constipation Sales by Region (2016-2021) (K Units)
Table 27. Global Opioid-Induced Constipation Sales Market Share by Region (2016-2021)
Table 28. Global Opioid-Induced Constipation Revenue by Region (2016-2021) & ($ Millions)
Table 29. Global Opioid-Induced Constipation Revenue Market Share by Region (2016-2021)
Table 30. Americas Opioid-Induced Constipation Sales by Country (2016-2021) & (K Units)
Table 31. Americas Opioid-Induced Constipation Sales Market Share by Country (2016-2021)
Table 32. Americas Opioid-Induced Constipation Revenue by Country (2016-2021) & ($ Millions)
Table 33. Americas Opioid-Induced Constipation Revenue Market Share by Country (2016-2021)
Table 34. Americas Opioid-Induced Constipation Sales by Type (2016-2021) & (K Units)
Table 35. Americas Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
Table 36. Americas Opioid-Induced Constipation Sales by Application (2016-2021) & (K Units)
Table 37. Americas Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
Table 38. APAC Opioid-Induced Constipation Sales by Region (2016-2021) & (K Units)
Table 39. APAC Opioid-Induced Constipation Sales Market Share by Region (2016-2021)
Table 40. APAC Opioid-Induced Constipation Revenue by Region (2016-2021) & ($ Millions)
Table 41. APAC Opioid-Induced Constipation Revenue Market Share by Region (2016-2021)
Table 42. APAC Opioid-Induced Constipation Sales by Type (2016-2021) & (K Units)
Table 43. APAC Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
Table 44. APAC Opioid-Induced Constipation Sales by Application (2016-2021) & (K Units)
Table 45. APAC Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
Table 46. Europe Opioid-Induced Constipation Sales by Country (2016-2021) & (K Units)
Table 47. Europe Opioid-Induced Constipation Sales Market Share by Country (2016-2021)
Table 48. Europe Opioid-Induced Constipation Revenue by Country (2016-2021) & ($ Millions)
Table 49. Europe Opioid-Induced Constipation Revenue Market Share by Country (2016-2021)
Table 50. Europe Opioid-Induced Constipation Sales by Type (2016-2021) & (K Units)
Table 51. Europe Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
Table 52. Europe Opioid-Induced Constipation Sales by Application (2016-2021) & (K Units)
Table 53. Europe Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
Table 54. Middle East & Africa Opioid-Induced Constipation Sales by Country (2016-2021) & (K Units)
Table 55. Middle East & Africa Opioid-Induced Constipation Sales Market Share by Country (2016-2021)
Table 56. Middle East & Africa Opioid-Induced Constipation Revenue by Country (2016-2021) & ($ Millions)
Table 57. Middle East & Africa Opioid-Induced Constipation Revenue Market Share by Country (2016-2021)
Table 58. Middle East & Africa Opioid-Induced Constipation Sales by Type (2016-2021) & (K Units)
Table 59. Middle East & Africa Opioid-Induced Constipation Sales Market Share by Type (2016-2021)
Table 60. Middle East & Africa Opioid-Induced Constipation Sales by Application (2016-2021) & (K Units)
Table 61. Middle East & Africa Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
Table 62. Key and Potential Regions of Opioid-Induced Constipation
Table 63. Key Application and Potential Industries of Opioid-Induced Constipation
Table 64. Key Challenges of Opioid-Induced Constipation
Table 65. Key Trends of Opioid-Induced Constipation
Table 66. Opioid-Induced Constipation Distributors List
Table 67. Opioid-Induced Constipation Customer List
Table 68. Global Opioid-Induced Constipation Sales Forecast by Region (2021-2026) & (K Units)
Table 69. Global Opioid-Induced Constipation Consumption Market Forecast by Region
Table 70. Global Opioid-Induced Constipation Revenue Forecast by Region (2021-2026) & ($ millions)
Table 71. Global Opioid-Induced Constipation Revenue Market Share Forecast by Region (2021-2026)
Table 72. Americas Opioid-Induced Constipation Sales Forecast by Country (2021-2026) & (K Units)
Table 73. Americas Opioid-Induced Constipation Revenue Forecast by Country (2021-2026) & ($ millions)
Table 74. APAC Opioid-Induced Constipation Sales Forecast by Region (2021-2026) & (K Units)
Table 75. APAC Opioid-Induced Constipation Revenue Forecast by Region (2021-2026) & ($ millions)
Table 76. Europe Opioid-Induced Constipation Sales Forecast by Country (2021-2026) & (K Units)
Table 77. Europe Opioid-Induced Constipation Revenue Forecast by Country (2021-2026) & ($ millions)
Table 78. Middle East & Africa Opioid-Induced Constipation Sales Forecast by Country (2021-2026) & (K Units)
Table 79. Middle East & Africa Opioid-Induced Constipation Revenue Forecast by Country (2021-2026) & ($ millions)
Table 80. Global Opioid-Induced Constipation Sales Forecast by Type (2021-2026) & (K Units)
Table 81. Global Opioid-Induced Constipation Sales Market Share Forecast by Type (2021-2026)
Table 82. Global Opioid-Induced Constipation Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 83. Global Opioid-Induced Constipation Revenue Market Share Forecast by Type (2021-2026)
Table 84. Global Opioid-Induced Constipation Sales Forecast by Application (2021-2026) & (K Units)
Table 85. Global Opioid-Induced Constipation Sales Market Share Forecast by Application (2021-2026)
Table 86. Global Opioid-Induced Constipation Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 87. Global Opioid-Induced Constipation Revenue Market Share Forecast by Application (2021-2026)
Table 88. Takeda Pharmaceuticals Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 89. Takeda Pharmaceuticals Opioid-Induced Constipation Product Offered
Table 90. Takeda Pharmaceuticals Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 91. Takeda Pharmaceuticals Main Business
Table 92. Takeda Pharmaceuticals Latest Developments
Table 93. Bayer Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 94. Bayer Opioid-Induced Constipation Product Offered
Table 95. Bayer Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 96. Bayer Main Business
Table 97. Bayer Latest Developments
Table 98. Sanofi Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Opioid-Induced Constipation Product Offered
Table 100. Sanofi Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Mallinckrodt Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 104. Mallinckrodt Opioid-Induced Constipation Product Offered
Table 105. Mallinckrodt Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 106. Mallinckrodt Main Business
Table 107. Mallinckrodt Latest Developments
Table 108. Salix (Bausch Health) Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 109. Salix (Bausch Health) Opioid-Induced Constipation Product Offered
Table 110. Salix (Bausch Health) Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 111. Salix (Bausch Health) Main Business
Table 112. Salix (Bausch Health) Latest Developments
Table 113. AstraZeneca Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 114. AstraZeneca Opioid-Induced Constipation Product Offered
Table 115. AstraZeneca Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 116. AstraZeneca Main Business
Table 117. AstraZeneca Latest Developments
Table 118. Progenics Pharmaceuticals Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 119. Progenics Pharmaceuticals Opioid-Induced Constipation Product Offered
Table 120. Progenics Pharmaceuticals Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 121. Progenics Pharmaceuticals Main Business
Table 122. Progenics Pharmaceuticals Latest Developments
Table 123. Purdue Pharm Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 124. Purdue Pharm Opioid-Induced Constipation Product Offered
Table 125. Purdue Pharm Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 126. Purdue Pharm Main Business
Table 127. Purdue Pharm Latest Developments
Table 128. Nektar Therapeutics Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 129. Nektar Therapeutics Opioid-Induced Constipation Product Offered
Table 130. Nektar Therapeutics Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 131. Nektar Therapeutics Main Business
Table 132. Nektar Therapeutics Latest Developments
Table 133. Daiichi Sankyo Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 134. Daiichi Sankyo Opioid-Induced Constipation Product Offered
Table 135. Daiichi Sankyo Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 136. Daiichi Sankyo Main Business
Table 137. Daiichi Sankyo Latest Developments
Table 138. Prestige Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 139. Prestige Opioid-Induced Constipation Product Offered
Table 140. Prestige Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 141. Prestige Main Business
Table 142. Prestige Latest Developments
Table 143. GSK Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 144. GSK Opioid-Induced Constipation Product Offered
Table 145. GSK Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 146. GSK Main Business
Table 147. GSK Latest Developments
Table 148. Shionogi Basic Information, Opioid-Induced Constipation Manufacturing Base, Sales Area and Its Competitors
Table 149. Shionogi Opioid-Induced Constipation Product Offered
Table 150. Shionogi Opioid-Induced Constipation Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2021E)
Table 151. Shionogi Main Business
Table 152. Shionogi Latest Developments
List of Figures
Figure 1. Picture of Opioid-Induced Constipation
Figure 2. Opioid-Induced Constipation Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Opioid-Induced Constipation Sales Growth Rate 2016-2026 (K Units)
Figure 7. Global Opioid-Induced Constipation Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. Opioid-Induced Constipation Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Methylnaltrexone Bromide
Figure 10. Product Picture of Lubiprostone
Figure 11. Product Picture of Naloxegol
Figure 12. Product Picture of Others
Figure 13. Global Opioid-Induced Constipation Sales Market Share by Type in 2020
Figure 14. Global Opioid-Induced Constipation Revenue Market Share by Type (2016-2021)
Figure 15. Opioid-Induced Constipation Consumed in Hospital
Figure 16. Global Opioid-Induced Constipation Market: Hospital (2016-2021) & (K Units)
Figure 17. Opioid-Induced Constipation Consumed in Pharmacy
Figure 18. Global Opioid-Induced Constipation Market: Pharmacy (2016-2021) & (K Units)
Figure 19. Opioid-Induced Constipation Consumed in Other
Figure 20. Global Opioid-Induced Constipation Market: Other (2016-2021) & (K Units)
Figure 21. Global Opioid-Induced Constipation Sales Market Share by Application (2016-2021)
Figure 22. Global Opioid-Induced Constipation Revenue Market Share by Application in 2020
Figure 23. Opioid-Induced Constipation Revenue Market by Company in 2020 ($ Million)
Figure 24. Global Opioid-Induced Constipation Revenue Market Share by Company in 2020
Figure 25. Global Opioid-Induced Constipation Sales Market Share by Regions (2016-2021)
Figure 26. Global Opioid-Induced Constipation Revenue Market Share by Region in 2020
Figure 27. Americas Opioid-Induced Constipation Sales 2016-2021 (K Units)
Figure 28. Americas Opioid-Induced Constipation Revenue 2016-2021 ($ Millions)
Figure 29. APAC Opioid-Induced Constipation Sales 2016-2021 (K Units)
Figure 30. APAC Opioid-Induced Constipation Revenue 2016-2021 ($ Millions)
Figure 31. Europe Opioid-Induced Constipation Sales 2016-2021 (K Units)
Figure 32. Europe Opioid-Induced Constipation Revenue 2016-2021 ($ Millions)
Figure 33. Middle East & Africa Opioid-Induced Constipation Sales 2016-2021 (K Units)
Figure 34. Middle East & Africa Opioid-Induced Constipation Revenue 2016-2021 ($ Millions)
Figure 35. Americas Opioid-Induced Constipation Sales Market Share by Country in 2020
Figure 36. Americas Opioid-Induced Constipation Revenue Market Share by Country in 2020
Figure 37. Americas Opioid-Induced Constipation Sales Market Share by Type in 2020
Figure 38. Americas Opioid-Induced Constipation Sales Market Share by Application in 2020
Figure 39. United States Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 40. Canada Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 41. Mexico Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 42. Brazil Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 43. APAC Opioid-Induced Constipation Sales Market Share by Region in 2020
Figure 44. APAC Opioid-Induced Constipation Revenue Market Share by Regions in 2020
Figure 45. APAC Opioid-Induced Constipation Sales Market Share by Type in 2020
Figure 46. APAC Opioid-Induced Constipation Sales Market Share by Application in 2020
Figure 47. China Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 48. Japan Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 49. Korea Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 50. Southeast Asia Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 51. India Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 52. Australia Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 53. Europe Opioid-Induced Constipation Sales Market Share by Country in 2020
Figure 54. Europe Opioid-Induced Constipation Revenue Market Share by Country in 2020
Figure 55. Europe Opioid-Induced Constipation Sales Market Share by Type in 2020
Figure 56. Europe Opioid-Induced Constipation Sales Market Share by Application in 2020
Figure 57. Germany Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 58. France Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 59. UK Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 60. Italy Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 61. Russia Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 62. Middle East & Africa Opioid-Induced Constipation Sales Market Share by Country in 2020
Figure 63. Middle East & Africa Opioid-Induced Constipation Revenue Market Share by Country in 2020
Figure 64. Middle East & Africa Opioid-Induced Constipation Sales Market Share by Type in 2020
Figure 65. Middle East & Africa Opioid-Induced Constipation Sales Market Share by Application in 2020
Figure 66. Egypt Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 67. South Africa Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 68. Israel Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 69. Turkey Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 70. GCC Country Opioid-Induced Constipation Revenue Growth 2016-2021 ($ Millions)
Figure 71. Channels of Distribution
Figure 72. Distributors Profiles
Request Sample
Request Discount
